Commissioner in charge of Health and Consumer Policy, John Dalli, said: "The Communication adopted today is a response to calls from the European Parliament and Member States to launch a specific EU policy on this sensitive issue. I believe that the temporary suspension constitutes a realistic and feasible solution to respond to the present welfare concerns ". The commissioner underlined that the proposal will not suspend cloning for uses other than food, such as research, conservation of endangered species or use of animals for the production of pharmaceuticals. In conclusion, he expressed the hope that "with the adoption of this report, the Council, the Parliament and the Commission will move forward on the proposal on Novel Foods which is an important contribution to consumer protection and innovation".
The way forward
In the Commission's view, a selective mixture of measures, accompanied by a review clause after five years, is the best way forward to address the issue. These measures will sufficiently address animal welfare concerns without introducing unnecessary and unjustifiable restrictions.
The Commission's assessment
The communication presents an assessment of cloning technology in relation to food production and examines the relevant aspects of cloning in light of the existing legislative framework. It acknowledges the challenges posed by animal welfare issues and takes into consideration the ethical facet of cloning. It also notes that there is no scientific evidence confirming food safety concerns regarding foods obtained from cloned animals or their offspring.
The communication examines cloning both in the Member States and in third countries. In the EU, the imports, trade and use of products from clones are currently covered by general EU legislation. Denmark is the only Member State that has imposed a national ban on the use of animal cloning for commercial purposes, while some third countries are already using cloning to produce breeding animals.
The Commission consulted stakeholders, asked EFSA to update scientific issues and took into account the opinion of the European Group of Ethics.